Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class

Bousquet, 2008, Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen), Allergy, 63, S8, 10.1111/j.1398-9995.2007.01620.x

Valovirta, 2007, The voice of the patients: allergic rhinitis is not a trivial disease, Curr Opin Allergy Immunol, 8, 1, 10.1097/ACI.0b013e3282f3f42f

Kohler, 2007, The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring, Eur Respir J, 30, 1208, 10.1183/09031936.00032007

Bousquet, 2006, Severity and impairment of allergic rhinitis in patients consulting in primary care, J Allergy Clin Immunol, 117, 158, 10.1016/j.jaci.2005.09.047

Lamb, 2006, Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective, Curr Med Res Opin, 22, 1203, 10.1185/030079906X112552

Hemp, 2004, Presenteeism: at work—but out of it, Harvard Business Review, 49

Kaliner, 2007, A novel and effective approach to treating rhinitis with nasal antihistamines, Ann Allergy Asthma Immunol, 99, 383, 10.1016/S1081-1206(10)60560-1

Bende, 2002, A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis, Ann Allergy Asthma Immunol, 88, 617, 10.1016/S1081-1206(10)61894-7

Bernstein, 1997, Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 79, 443, 10.1016/S1081-1206(10)63041-4

Bjerrum, 1985, Treatment of seasonal allergic rhinitis with budesonide and disodium cromoglycate, Allergy, 40, 65, 10.1111/j.1398-9995.1985.tb04156.x

Bronsky, 1997, Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 79, 51, 10.1016/S1081-1206(10)63084-0

Bronsky, 1998, Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies, Allergy Asthma Proc, 19, 135, 10.2500/108854198778604112

Chen, 2006, Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2–6yr, Pediatr Allergy Immunol, 17, 49, 10.1111/j.1399-3038.2005.00351.x

Chervinsky, 2005, Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis, Allergy Asthma Proc, 26, 391

deBlic, 2005, Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial, Pediatr Allergy Immunol, 16, 267, 10.1111/j.1399-3038.2005.00216.x

Gehanno, 1997, Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis, Allergy, 52, 10.1111/j.1398-9995.1997.tb01027.x

Hampel, 2006, Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCL nasal spray 0.6% compared with vehicle placebo, Allergy Asthma Proc, 27, 202, 10.2500/aap.2006.27.2862

Hampel, 2003, Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 91, 354, 10.1016/S1081-1206(10)61682-1

Howarth, 1999, Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis, J Allergy Clin Immunol, 104, 927, 10.1016/S0091-6749(99)70070-9

Kaiser, 2007, Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis, J Allergy Clin Immunol, 119, 1430, 10.1016/j.jaci.2007.02.022

Kim, 2006, Desloratadine therapy for symptoms associated with perennial allergic rhinitis, Ann Allergy Asthma Immunol, 96, 460, 10.1016/S1081-1206(10)60914-3

LaForce, 2004, Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine, Ann Allergy Asthma Immunol, 93, 154, 10.1016/S1081-1206(10)61468-8

Martin, 2006, Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms, Ann Allergy Asthma Immunol, 96, 851, 10.1016/S1081-1206(10)61349-X

Murris-Espin, 1998, Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis, Ann Allergy Asthma Immunol, 80, 399, 10.1016/S1081-1206(10)62991-2

Nathan, 2008, Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis, Ann Allergy Asthma Immunol, 100, 497, 10.1016/S1081-1206(10)60477-2

Noonan, 2003, The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial, Clin Exp Allergy, 33, 351, 10.1046/j.1365-2222.2003.01596.x

Potter, 2005, Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial, Ann Allergy Asthma Immunol, 95, 175, 10.1016/S1081-1206(10)61208-2

Potter, 2003, Levocetirizine is effective for symptoms relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites, Allergy, 58, 893, 10.1034/j.1398-9995.2003.00171.x

Ratner, 2005, Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar, Ann Allergy Asthma Immunol, 95, 474, 10.1016/S1081-1206(10)61174-X

Ratner, 2003, Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast, Ann Allergy Asthma Immunol, 90, 536, 10.1016/S1081-1206(10)61847-9

Storms, 1989, SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis, J Allergy Clin Immunol, 83, 1083, 10.1016/0091-6749(89)90450-8

Sussman, 1999, The efficacy and safety of fexofenadine HCL and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis, J Allergy Clin Immunol, 104, 100, 10.1016/S0091-6749(99)70120-X

Sy, 1979, Flunisolide intranasal spray in the treatment of perennial rhinitis, Arch Otolaryngol, 105, 649, 10.1001/archotol.1979.00790230019004

Van Adelsberg, 2003, Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period, Allergy, 58, 1268, 10.1046/j.1398-9995.2003.00261.x

Warland, 1982, Evaluation of flunisolide nasal solution in the symptomatic treatment of perennial rhinitis, Allergy, 37, 417, 10.1111/j.1398-9995.1982.tb02320.x

Wilson, 2001, A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma, Clin Exp Allergy, 31, 616, 10.1046/j.1365-2222.2001.01088.x

Wilson, 2002, Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis, Clin Exp Allergy, 32, 1504, 10.1046/j.1365-2745.2002.01509.x

Wilson, 2002, A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis, Clin Exp Allergy, 32, 126, 10.1046/j.0022-0477.2001.01252.x

Wilson, 2001, Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis, Clin Exp Allergy, 31, 61, 10.1046/j.1365-2222.2001.00964.x

2006

Weiner, 1998, Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials, BMJ, 317, 1624, 10.1136/bmj.317.7173.1624